Clinical Trials

Clinical Trials of interest to cytokine & interferon researchers.

Interferon-α for TP53 Myeloid Malignancy Post Allo-HSCT
ClinicalTrials.gov ID NCT06130579
Sponsor: Peking University People’s Hospital
Information provided by Xiao-Jun Huang, Peking University People’s Hospital (Responsible Party)
Last Update Posted 2024-03-21

MITHRIDATE: Ruxolitinib Versus Hydroxycarbamide or Interferon as First Line Therapy in High Risk Polycythemia Vera (MITHRIDATE)
ClinicalTrials.gov ID NCT04116502
Sponsor: University of Birmingham
Information provided by University of Birmingham (Responsible Party)
Last Update Posted 2024-05-10

Effect of Low-dose Interferon-alfa2a on Peri-operative Immune Suppression (IPOS)
ClinicalTrials.gov ID NCT04798612
Sponsor: Zealand University Hospital
Information provided by Zealand University Hospital (Responsible Party)
Last Update Posted 2023-08-18

Stephanie Flores Managing Director

ICIS Co-Managing Director Supports the leadership and governance of the Society and represents the organization. Works with the Governing Council to set and implement the strategic direction and ensure the organization meets its objectives. It is also my responsibility to ensure compliance with the Society's bylaws, policies and all applicable regulations.

See Full Bio